Sailing-Racing sailors to double as ocean scientists in European waters
The fleet will gather measurements on water temperature, salinity, oxygen, CO2 levels, microplastics and environmental DNA during the offshore competition from August 10 to September 20.
Some teams will deploy drifter buoys designed to transmit meteorological information for years afterward.
"We know conditions in our ocean are changing rapidly but scientists need more data to better understand what is happening, the pace of change and how this impacts ocean health," said Lucy Hunt, Ocean Impact Director of The Ocean Race and a marine biologist.
"Due to the vastness of the ocean, reliable data is very sparse, and there are many areas that are undersampled."
The race begins in Kiel, Germany and visits Portsmouth, Porto, Cartagena, Nice, Genova, and Montenegro's Boka Bay.
Organisers report that the 2023 around-the-world race generated more than 4 million data points for researchers.
"By putting different configurations of The Ocean Race Science Instruments on different race boats we can broaden the scope of the data we collect," said Stefan Raimund, Scientific Advisor to The Ocean Race.
The Ocean Race Europe is a multi-stage offshore sailing competition organised by the same group behind the round-the-world Ocean Race. It features top-tier IMOCA 60 and VO65 yachts crewed by mixed-gender teams.
The IMOCA 60 and VO65 are elite ocean racing yachts at the heart of major offshore events.
The 60-foot IMOCA is a foiling, carbon-fibre monohull designed for solo or short-handed races, while the 65-foot VO65 is a one-design yacht used in fully crewed races like The Ocean Race.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
34 minutes ago
- Yahoo
Elbit Systems discloses $1.6bn European order, reports higher Q2 results; stock up
-- Elbit Systems (NASDAQ:ESLT) shares popped around 6% in premarket trading Wednesday after the military technology company reported higher second-quarter revenue and profit on Wednesday, alongside securing a major new defense contract. Elbit announced it has been awarded a $1.635 billion contract to supply a range of defense solutions to an undisclosed European country, with implementation over five years. The company's second-quarter revenue rose 21% year-on-year to $1.9 billion. On a non-GAAP basis, net profit climbed 63% to $151 million, or $3.23 per share, while earnings per share were $2.69 compared with $1.76 a year earlier. The company's order backlog reached $23.8 billion at the end of the quarter, up $700 million from the prior period. About 68% of the backlog comes from customers outside Israel, and roughly 46% is scheduled for delivery in the remainder of 2025 and 2026. Related articles Elbit Systems discloses $1.6bn European order, reports higher Q2 results; stock up Victoria's Secret Exposed: The Warning Sign Behind the Stock's 52% Collapse If Powell goes, does Fed trust go with him? Sign in to access your portfolio
Time Magazine
37 minutes ago
- Time Magazine
Using AI Made Doctors Worse at Spotting Cancer Without Assistance
Health practitioners, companies, and others have for years hailed the potential benefits of AI in medicine, from improving medical imaging to outperforming doctors at diagnostic assessments. The transformative technology has even been predicted by AI enthusiasts to one day help find a 'cure to cancer.' But a new study has found that doctors who regularly used AI actually became less skilled within months. The study, which was published on Wednesday in the Lancet Gastroenterology and Hepatology journal, found that over the course of six months, clinicians became over-reliant on AI recommendations and became themselves 'less motivated, less focused, and less responsible when making cognitive decisions without AI assistance.' It's the latest study to demonstrate potential adverse outcomes on AI users. An earlier study by the Massachusetts Institute of Technology found that ChatGPT eroded critical thinking skills. How the study was conducted Researchers across various European institutions conducted an observational study surveying four endoscopy centers in Poland that participated in the Artificial Intelligence in Colonoscopy for Cancer Prevention (ACCEPT) trial. The study was funded by the European Commission and Japan Society for the Promotion of Science. As part of the trial, the centers had introduced AI tools for the detection of polyps—growths that can be benign or cancerous—in late 2021. The study looked at 1,443 non-AI-assisted colonoscopies out of a total 2,177 colonoscopies conducted between September 2021 and March 2022. The colonoscopies were performed by 19 experienced endoscopists. Researchers compared the quality of colonoscopy conducted three months before and three months after AI was implemented. Colonoscopies were conducted either with or without AI assistance, at random. Of those conducted without AI assistance, 795 were conducted before regular AI use was implemented and 648 were conducted after the AI tools were introduced. What the study found Three months before AI was introduced, the adenoma detection rate (ADR) was around 28%. Three months after AI was introduced, the rate dropped to 22% when clinicians were unassisted by AI. ADR is a commonly used quality indicator for colonoscopies and represents 'the proportion of screening colonoscopies performed by a physician that detect at least one histologically confirmed colorectal adenoma or adenocarcinoma.' Adenomas are precancerous growths, and a higher ADR is associated with a lower risk of colorectal cancer. The study found that AI did help endoscopists with detection when used, but once the assistance was removed, clinicians were worse at detection. Researchers attributed it to 'the natural human tendency to over-rely' on the recommendations of decision support systems like AI. 'Imagine that you want to travel anywhere, and you're unable to use Google Maps,' Marcin Romańczyk, co-author of the study and an assistant professor at the Medical University of Silesia, told MedPage Today. 'We call it the Google Maps effect. We try to get somewhere, and it's impossible to use a regular map. It works very similarly.' Implications of the study Omer Ahmad, a consultant gastroenterologist at University College Hospital London who wrote an editorial alongside the study but was not involved in its research, tells TIME that it's likely that exposure to AI weakened doctors' visual search habits and alerting gaze patterns, which are critical for detecting polyps. 'In essence, dependence on AI detection could dull human pattern recognition,' Ahmad says. He adds that regular use of AI could also 'reduce diagnostic confidence' when AI assistance is withdrawn, or that the endoscopists' skill of manoeuvring the colonoscope could be reduced. In comments to the Science Media Center (SMC), Catherine Menon, principal lecturer at the University of Hertfordshire's Department of Computer Science, said: 'Although de-skilling resulting from AI use has been raised as a theoretical risk in previous studies, this study is the first to present real-world data that might potentially indicate de-skilling arising from the use of AI in diagnostic colonoscopies.' Menon raised concerns that overreliance on AI could leave health practitioners at risk to technological compromise. Other experts are more cautious about drawing conclusions from a single study. Venet Osmani, a professor of clinical AI and machine learning at Queen Mary University of London, noted to SMC that the total number of colonoscopies—including both AI-assisted and non-AI-assisted ones—increased over the course of the study. The increased workload, Osmani suggested, could have led to clinician fatigue and poorer detection rates. Allan Tucker, a professor of artificial intelligence at Brunel University of London, also noted that with AI assistance, clinician performance improved overall. Concerns about deskilling due to automation bias, added Tucker to SMC, 'is not unique to AI systems and is a risk with the introduction of any new technology.' 'The ethical question then is whether we trust AI over humans,' said Tucker. 'Often, we expect there to be a human overseeing all AI decision-making but if the human experts are putting less effort into their own decisions as a result of introducing AI systems this could be problematic.' 'This is not simply about monitoring technology,' says Ahmad. 'It's about navigating the complexities of a new human-AI clinical ecosystem.' Establishing safeguards is critical, he adds, suggesting that beyond this study, people may need to focus on 'preserving essential skills in a world where AI becomes ubiquitous.'
Yahoo
an hour ago
- Yahoo
Cats Have Given Alzheimer's Scientists Hope For Breakthrough Research
A study recently published in the European Journal of Neuroscience has found that cats appear to develop a version of dementia in similar ways to humans. Feline cognitive dysfunction syndrome (also known as feline dementia) tends to develop as cats age. It affects their sleep, socialising, and sense of orientation. As with humans, feline dementia seems to include a buildup of amyloid-beta proteins. Per the new paper, cats with feline cognitive dysfunction syndrome also experience 'brain atrophy, neuronal loss, amyloid-beta plaques, tau pathology and cerebral amyloid angiopathy' – all processes suspected to be a part of human dementia development. Why might this finding in cats help people with dementia? The University of Edinburgh scientists looked at the brains of 25 cats who had died. They were of different ages, and some had 'feline dementia'. After looking at 'powerful microscopy images', the researchers found a higher amyloid plaque buildup between the synapses of older cats and those with feline dementia. The team also found that some cells in the brain engulfed, or 'ate', affected synapses (sometimes known as synaptic pruning). Though this process is often helpful to keeping your brain healthy, in those with dementia, the loss of these synapses 'strongly predicts reduced memory and thinking abilities in humans with Alzheimer's disease', the University of Edinburgh explained. The scientists say the apparent similarity between cat and human dementia development means felines could provide a 'naturally occurring, translational' model of dementia for future researchers. Dr Robert McGeachan, the study's lead author, said: 'Dementia is a devastating disease – whether it affects humans, cats, or dogs. 'Because cats naturally develop these brain changes, they may... offer a more accurate model of the disease than traditional laboratory animals, ultimately benefiting both species and their caregiver.' Will this help cats with dementia, too? The researchers highlighted the potential to help our pets with dementia through future research as well. Professor Danièlle Gunn-Moore, a co-author of the study, said: 'Feline dementia is so distressing for the cat and for its person. It is by undertaking studies like this that we will understand how best to treat them. 'This will be wonderful for the cats, their owners, people with Alzheimer's and their loved ones. Feline dementia is the perfect natural model for Alzheimer's; everyone benefits.' Related... This Exercise Type May Reduce Dementia Risk By 88% This Lifestyle Change May Delay Dementia And Heart Disease As You Age Today's 70-Year-Old's Less Likely To Have Dementia Than Past Generations – Is This Why?
